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SUMMARY 
This paper reports on a patient record survey that was undertaken with the central aim of establishing reliable, baseline 
information to inform strategic planning and organisation of future CAMHS in Malta. The records of the total population of children 
and adolescents admitted into the psychatric hospital over a five year period were surveyed. Results showed that the characteristics 
and circumstances of children and adolescents with mental disorder and comorbid substance misuse in Malta are similar to those 
described in international studies. The survey emphasised the pressing need for further research into this sub group and also 
highlighted gaps in reliable data systems locally. 
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INTRODUCTION 
Setting the scene 
Malta, consisting of three main islands with an area 
of 315 km2, is situated at the centre of the Medi-
terranean. It has the highest population density in 
Europe combined with the lowest total population of 
any European Union Member State (Azzopardi Muscat 
et al. 2014). In 2011, a national census established the 
total Maltese population as being 417,432. Of these, 
76,885 (18%) were aged 17 or under (National Statistics 
Office 2012). Like most countries in Europe, the public 
health system faces significant challenges, not least in 
the area of mental health. Despite notable improvements 
in services for people suffering from mental disorders in 
recent years, strategic planning and policy makers 
recognise that this is a sector that requires major 
development in order to bring it in line with the present 
international standards for good practice in this field 
(Ministry for Health 2014). At present, in Malta we are 
updating our mental health policy and there is currently 
no precise data available regarding mental disorder 
amongst the population in general nor regarding specific 
sub groups. As in most European countries, child and 
adolescent mental health services (CAMHS) operate 
from a range of settings, however there is only one 
psychiatric hospital which serves the population of 
Malta. CAMHS are based on a multi-disciplinary team 
approach. The teams are led by Consultant Psychiatrists 
and are made up of medical doctors, psychologists, 
social workers, educators, specialist nurses, general 
nurses and care staff. 
 
Background 
The wellbeing of children is increasingly at the 
centre of policy and practice development across many 
countries, not least since it is generally accepted that the 
mental health of children is an essential part of health 
development with long term implications for both the 
child and the family when ill health occurs (Joint 
Commissioning Panel for Mental Health 2013). In fact 
child and adolescent mental health is receiving growing 
attention worldwide due to factors such as an increasing 
awareness of the accumulative negative consequences 
of poor mental health amongst young people; the 
advances made in diagnosis and treatment of these 
disorders and demands from families and communities 
for appropriate serves in an increasingly consumer led 
healthcare environment. By 2020, mental and substance 
use disorders will surpass all physical diseases as a 
major cause of disability worldwide (SAMHSA 2014). 
Co morbidity of mental health and substance misuse 
issues are common among young people and can have 
enormous repercussions on individuals, families, 
communities and health systems (Salvo et al. 2012, 
Canadian Centre on Substance Abuse 2013, SAMHSA 
2014). Moreover, people with a mental health issue are 
more likely to use alcohol or drugs than those not 
affected by a mental illness (Canadian Centre on 
Substance Abuse 2013). Co-morbidity can determine a 
etiology, cause a diagnostic dilemma and may influence 
the clinical presentation, the course, the treatment 
strategies and the outcome of both co morbid conditions 
(Swadi 2002). Salvo et al. (2012) reviewed compelling 
research based evidence of the increased risk for 
substance misuse amongst under 18’s. This study 
reported that children and adolescents with both a 
mental disorder and substance abuse disorder are 
difficult to manage and one disorder exacerbates the 
other. When combined they often lead to family 
dysfunction, delinquency and reduced life opportunities, 
further complicated by poor treatment compliance and 
poor outcomes, both in the short and long-term. This 
Anton Grech & Sally Axiak: A NATIONAL SNAPSHOT OF SUBSTANCE MISUSE AMONG CHILD AND ADOLESCENT  
PSYCHIATRIC INPATIENTS IN MALTA          Psychiatria Danubina, 2015; Vol. 27, Suppl. 1, pp 353–356 
 
 
 S354 
view is supported by the National Treatment Agency 
(NTA) for Substance Misuse (UK) who observed that 
many of the adolescents presenting to child and adoles-
cent mental health services (CAMHS) show significant 
substance related problems. NTA research found that 
the presence of co-existing substance misuse compli-
cates the clinical course, treatment compliance and 
prognosis for these young people. Furthermore the con-
verse is also true: substances exacerbate and maintain 
psychiatric disorders. Disturbingly, the NTA noted that 
many youngsters who misuse substances do not receive 
adequate treatment, even the brief interventions that are 
relatively easily delivered in medical settings (NTA 
2008). 
As children leave their early childhood years and 
approach adolescence they encounter multiple, com-
plex, and challenging developmental tasks involving 
significant intertwined and overlapping changes in 
biological, social, psychological, and environmental/ 
societal domains. The multiplicity and complexity of 
this negates addressing issues in isolation of each other. 
Mental health needs cannot be separated from matters 
related to substance misuse. It is imperative to establish 
processes and protocols to better recognize and respond 
to the possibility of co-occurring diagnosis. 
 
The study 
The World Health Organisation (WHO) emphasised 
the importance of reliable data as a foundation when 
developing mental health policies and programmes 
(WHO 2005). Mental health is a neglected and an under 
researched area of public health and research generated 
information is considered crucial in determining needs, 
proposing new cost-effective interventions, monitoring 
their implementation and evaluating their effectiveness. 
Conceivably, such information will enable better uti-
lisation of limited mental health resources (Sharan 
2007). However, WHO (2005) also acknowledged that 
difficulties in obtaining such essential data are symp-
tomatic of a worldwide challenge faced by those 
interested in promoting mental health and providing 
services for those who need them.  
All organisations that are pursuing objectives in a 
health, social and economic environment are concer-
ned with establishing and examining their own perfor-
mance and planning ways to refine and improve 
services. To this end, in an attempt to capture a 
national snapshot of the socio-demographic characte-
ristics of child and adolescent mental health services 
(CAMHS) users, and details regarding their contact 
with, and uptake of inpatient services, a retrospective 
survey of patients’ case notes was undertaken.  
This report focuses on just one data set that 
emanated from the survey, specifically substance 
misuse amongst the population under study. The 
findings of the survey allowed the following crucial 
questions to be answered: of the total number of 
children and adolescents who received inpatient 
psychiatric services over a five year period, how many 
report substance misuse? What are the main 
characteristics of this patient group?  
The central aim of the exercise was to establish 
reliable, baseline information to inform strategic 
planning and organisation of future CAMHS that reflect 
Malta’s unique needs, whilst heeding the financial and 
resource limitations and restraints that all public health 
services are subject to. 
 
SUBJECTS AND METHODS 
Subjects 
The population under study were children and 
adolescents who were inpatients either in the young 
person’s psychiatric unit or in adult acute psychiatric 
wards of Malta’s only psychiatric hospital between 1st 
July 2010 and 31st July 2014.  
 
Method 
This study was a retrospective record survey. A data 
gathering instrument was devised in order to conduct 
systematic examination and verification of factors 
related to the total population of in patients under 18 
years of age during a five year period (2010 to 2014). It 
included 46 data points, and information mined from the 
records ranged from basic demographics, to diagnoses, 
medication, length of stay and co morbidity of 
substance misuse. 
 
RESULTS 
There were 212 child or adolescent admission to in-
patient services during the period surveyed. 102 cases 
were recorded to have misused one or more substances. 
In the remaining 110 cases there was missing or 
incomplete information available. Of these recorded 
cases, 56 % were male patients and 44% were female 
patients. The majority of the cases misusing substances 
(96.1%) were in the age group of 11-18 years, with only 
4 recorded cases between the age of 4-10 years. There 
were a higher percentage of recorded cases living in 
socially deprived areas (over 30%) and single parent 
households. 46% of recorded cases were from single 
parent households, 34% both parents, and 22% from 
state run homes or facilities. When comparing primary 
diagnosis on admission in each case against misuse of 
substances, conduct disorder was the predominant 
diagnosis in the majority of cases (29%). This was 
reaffirmed by primary diagnosis on discharge, as 31% 
of cases were diagnosed with conduct disorder. In 55% 
of cases, patients had previous service contact with 
mental health services. Figure 1 indicates the types of 
substances misused by gender (in some cases more than 
one substance was involved). 
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Figure 1. Substances used (misused) by gender 
 
DISCUSSION 
The prevalence of substance misuse amongst child 
and adolescent patients with a mental disorder can be 
seen to be in line with other countries. Nageotte and 
Murphy (2000) stated that in the United States of 
America (USA) 40–70% of adolescents admitted to 
mental health facilities have at least one significant 
drug or alcohol problem. Swadi (2002) reported that 
data specific to New Zealand, indicated that about two 
thirds of inpatient youths with a severe psychiatric 
disorder have a co morbid substance abuse disorder. In 
the UK, a national research briefing looking at the 
relationship between substance misuse and mental 
health issues, suggested that the prevalence of comor-
bidity affects between 30 and 70 % of those presenting 
to health and social care settings (Crome 2009). 
Comorbidity of misuse of one or more substances was 
found in the sample surveyed in Malta to be 48% of 
total admissions. It is of some concern that comor-
bidity was not excluded in the remaining 52% (110 
cases), but rather could not be established due to incom-
plete records. This may suggest that the prevalence of 
comorbidity is higher than this survey suggests.  
Literature supports local findings regarding conduct 
disorder being the predominant primary diagnosis in 
comorbidity. Conduct disorder has long been recognised 
as being associated with substance misuse (Zeitlin 1999, 
Swadi 2002). According to Nageotte and Murphy 
(2000) conduct disorder is a real vulnerability factor for 
adolescent substance abuse. In Canada, research showed 
that approximately 25-50% of young people who have 
abused drugs have been diagnosed with conduct 
disorder or oppositional defiant disorder, whereas Riggs 
(2003) stated that 60-80% of adolescents who misuse 
substances have conduct disorder.  
Riggs (2003) stated that research reflects the rele-
vance of social problems and early childhood develop-
ment of a mental disorder as high risk factors for early 
substance misuse. The Canadian Centre on Substance 
Abuse (2013) also reported that early childhood adverse 
social experiences in patients with a mental disorder 
lead to a greater risk of substance misuse. Such reports 
are borne out locally since social deprivation and family 
factors appear to be correlated to substance misuse in 
this sample.  
When looking to the actual substances involved in 
this study, similar comparisons can be found in recent 
literature. Mangerud et al. (2014) conducted an exten-
sive study in Norway which examined frequencies of 
smoking, alcohol use and illicit drug use in over 500 
adolescent psychiatric patients. They found that pre-
valence of smoking is considerably higher in people 
with a psychiatric disorder than the general population, 
and people with a psychiatric disorder start smoking at a 
younger age and smoke more cigarettes per day than 
those with no mental illness. They stated that alcohol is 
often used as a means of self medication in patients with 
pscyhiatric disorders. The Norway study concluded that 
compared with adolescents in the general population, 
adolescent psychiatric patients had a higher prevalence 
of smoking and the chance of having tried illicit drugs 
increased by four times. Conversely they had a similar 
incidence of alcohol use as the general population. NTA 
research (2008) found that the most common drugs used 
are alcohol, tobacco, cannabis and combinations of the 
three. They also found that some young people occa-
sionally used ecstasy and that a small proportion of their 
client group, about 15-20%, showed class A drug abuse, 
mostly heroin and cocaine. 
There is consensus in the literature regarding preven-
tion and screening for substance misuse in this popu-
lation (Swadi 2002, Riggs 2003, Canadian Centre on 
Substance Abuse 2013). Swadi (2002) noted that early 
detection is paramount and is possible at the first point 
of contact through screening. 55% of cases in this study 
had prior contact with mental health services. Although 
no information is available as to whether substance 
misuse was recognised at initial contact, the possibility 
for early screening may well be unaddressed locally. 
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Limitations 
The main limitation of this study is the lack of 
available data which prevented a more rigourous and 
scientific approach to analysis to be employed. This also 
counteracted the strengths associated with surveying a 
total population, since in approximately 50% of cases, 
records were incomplete. Currently there are no 
comprehensive electronic patient information systems 
within mental health services and all data was mined 
from mainly handwritten notes. This meant that the 
process of gathering data was lengthy and laborious 
(taking around 12 weeks) and rendered the findings 
open to researcher interpretation.  
 
CONCLUSIONS 
This study was the first undertaking which attempted 
to chart the characteristics of children and adolesdcents 
with comorbid disorders in Malta. Although lacking 
generalisability to a wider audience it is an important 
first step in using researched evidence as a tool for 
future service policy and planning. Whilst the findings 
have shown that young people with comorbid disorders 
in Malta share many similarities in characteristics with 
similar children and adolescents in other countries, this 
study has also revealed that there is a clear and pressing 
nee d to develop research systems and conduct more 
detailed enquiries.  
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